Vertex Pharmaceuticals is seeking an Executive Director of Regulatory Strategy for its Cell & Gene Therapy portfolio focused on Type 1 Diabetes. This global leadership role manages a team of regulatory professionals and drives innovative strategies for development and commercialization.
A strong track record in pharmacovigilance, submissions, and health authority interactions is essential, with hybrid work options available.
#J-18808-Ljbffr
The Regulatory Strategy Executive – Cell & Gene Therapy (Hybrid) position in the Management & Operations field is open for applications.
The advertised compensation is 268.200 - 402.200.
We aim to respond to suitable candidates as soon as possible.
Full responsibilities and requirements are described in the listing above.
Learn more about the Regulatory Strategy Executive – Cell & Gene Therapy (Hybrid) role in the description above.
We appreciate your interest in this position.